|1.||Lazarev, A F: 5 articles (11/2014 - 05/2008)|
|2.||Klimachev, V V: 4 articles (09/2014 - 05/2008)|
|3.||Bobrov, I P: 4 articles (09/2014 - 05/2008)|
|4.||Gottwald, Leszek: 4 articles (02/2014 - 01/2003)|
|5.||Danilewicz, Marian: 4 articles (02/2014 - 01/2003)|
|6.||Suzin, Jacek: 4 articles (02/2014 - 01/2003)|
|7.||Lushnikova, E L: 3 articles (11/2014 - 11/2013)|
|8.||Kobyakov, D S: 3 articles (11/2014 - 11/2013)|
|9.||Avdalyan, A M: 3 articles (11/2014 - 11/2013)|
|10.||Nepomnyashchikh, L M: 3 articles (11/2014 - 11/2013)|
01/01/2001 - "Promising results of studies on different neoplasms, by means of morphometric analysis of argyrophilic nucleolar organizer regions (AgNORs), known as proliferative activity marker, made us undertake an attempt to evaluate of proliferative activity in Hürthle Cell Tumors using the same technique. "
08/01/1996 - "The actual growth rate did not discriminate between the disease-free surviving and deceased patients but the AgNORs content in Ki67 cells correlated with the survival time of those patients who died of the tumor. "
01/01/2005 - "Studies on nucleolar organiser regions (AgNors) in selected spontaneous and transplantable animal tumors."
01/01/2004 - "The present study aimed at examining the relationship between the manifestation intensity of proliferation markers (Ki-67 and nucleolar organizer regions--AgNORs) on one hand, and expression of ER and PgR on the other in a uniform group of invasive ductal breast cancers of G2 grade. "
07/01/2000 - "In the present study, we investigated argyrophilic nucleolar organizer regions (AgNORs) score, a well-known indicator for proliferative potential of the cancer cells, in 89 cases of DTC. "
01/01/1995 - "Argyrophil nucleolar organizer regions (AgNORs) were morphometrically evaluated in rat anterior pituitaries of control and oestrogenized rats using an automatized (LUCIA M--Laboratory Universal Computer Image Analysis Micro) and a non-automatized approaches to investigate not only the sensitivity and effectiveness of the automatized procedure but also the morphology of AgNORs in oestrogen-induced rat anterior pituitary hyperplasia. "
01/01/1995 - "Image analysis of argyrophil nucleolar organizer regions (AgNORs) in oestrogen-induced rat anterior pituitary hyperplasia: comparison of automatized (LUCIA M) and non-automatized evaluation."
04/01/1993 - "The areas of basal cell hyperplasia showed higher count more scatter and smaller AgNORs. "
11/01/1990 - "There was a significant difference in the mean number of AgNORs between any two groups (p less than 0.05), except for simple hyperplasia vs PN hyperplasia (p = 0.085). "
01/01/1990 - "PN hyperplasias were classified into two types based upon the mean number of AgNORs, indicating that they include reversible and irreversible changes in contrast with simple hyperplasia which is reversible change."
02/01/1993 - "However, the higher counts found in many carcinomas were due to dispersion of AgNORs within the nucleoplasm, so that the AgNOR type is helpful in making such a distinction. "
01/01/1991 - "Analysis of AgNORs, consequently, should provide prognostically relevant information helpful in more effective grading of urinary bladder carcinoma."
09/01/2014 - "AgNORs in ameloblastic carcinoma were more in number and more widely spread. "
01/01/2013 - "For this reason, a long-term analysis was carried out in regard to overall survival by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) to objectify tumour grading in the case of breast carcinoma.This"
01/01/2013 - "Long-term analysis to objectify the tumour grading by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) in the case of breast carcinoma."
05/01/1994 - "The results of gastric biopsies performed before and after treatment for H pylori showed that only patients who cleared the H pylori infection had a significant decrease in the number of AgNORs per nucleus. "
03/01/2009 - "Evaluate the relationships between AgNORs polymorphisms and squamous intraepithelial lesions (SIL) and squamous cell carcinoma (SCC) with HPV infection. "
08/01/1997 - "The numbers of argyrophilic nucleolar organizer regions (AgNORs) were quantified in oral carcinomas (n = 39) with or without human papillomavirus (HPV) infection. "
08/10/2003 - "[The relation between Helicobacter pylori infection and p53 mutation, MG-7 antigen and AgNORs expression in the development of gastric mucosa lesions]."
01/01/1995 - "AgNORs were studied in 24 biopsies from oral cavity (5 cases of normal oral mucosa, 5 of pseudocarcinomatous hyperplasia and 14 of squamous cell carcinoma, subdivided according to degree of differentiation: 5 grade 1, 5 grade 2 and 4 grade 3) to find whether they were helpful in distinguishing pseudocarcinomatous hyperplasia due to chronic parasitic infections from squamous cell carcinoma. "
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/01/2014 - "The study clearly indicates that in oral squamous cell carcinomas, AgNORs diminish in size as they increase in number. "
06/01/2014 - "The objective of this study was to carry out a quantitative assessment of large and small AgNORs in oral normal mucosa, precancerous lesions and infiltrating squamous cell carcinomas. "
10/01/2003 - "The study was aimed at assessing the cell proliferation in various grades of squamous cell carcinoma of cervix using two proliferation markers: AgNORs and Ki-67. "
01/01/2001 - "The aim of the study was the quantitative analysis of AgNORs in oral squamous cell carcinomas as well as in dysplastic epithelial changes accompanied and not accompanied by oral squamous cell carcinomas. "
12/01/1996 - "The purpose of this study was to assess the prognostic value of AgNORs expression in oral squamous cell carcinoma (SCC). "
|2.||Proliferating Cell Nuclear Antigen (PCNA)
|3.||Proteins (Proteins, Gene)
|5.||1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
|8.||Biological Markers (Surrogate Marker)
|9.||DNA (Deoxyribonucleic Acid)
|10.||nucleolar organizer region associated proteins
|2.||Drug Therapy (Chemotherapy)
|5.||Heterologous Transplantation (Xenotransplantation)